Qube Research & Technologies LTD Hookipa Pharma Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $1.04 $2 - $4	4 New	4 $0
Q3 2023 Nov 13, 2023	BUY	$0.58 - $0.91 $2 - $3	4 New	4 $0
Q3 2022 Nov 14, 2022	SELL	$1.27 - $15.0 $1,885 - $22,275	-1,485 Reduced 10.47%	12,704 $17,000
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.31 $18,871 - $32,776	14,189 New	14,189 $23,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.